
BioReact helps bioprocess teams accelerate process optimization and scale-up by turning disparate bioreactor and offline data into actionable insights. Their cloud-based AI platform automatically aligns online and offline data from virtually every bioreactor and offline source, visualizes datasets, and centralizes data for team collaboration. BioReact uses machine learning models trained on over 12 million data points across common cell lines (CHO, yeast, Pichia, HEK293, E. coli) to drive parameter optimization and experiment design. The product is a B2B SaaS for biopharma and biotech R&D that integrates with laboratory data sources and supports scientists during process development and scale-up.

BioReact helps bioprocess teams accelerate process optimization and scale-up by turning disparate bioreactor and offline data into actionable insights. Their cloud-based AI platform automatically aligns online and offline data from virtually every bioreactor and offline source, visualizes datasets, and centralizes data for team collaboration. BioReact uses machine learning models trained on over 12 million data points across common cell lines (CHO, yeast, Pichia, HEK293, E. coli) to drive parameter optimization and experiment design. The product is a B2B SaaS for biopharma and biotech R&D that integrates with laboratory data sources and supports scientists during process development and scale-up.
Company: BioReact — AI-powered bioprocess SaaS
Founded: 2023
Headquarters: Indianapolis, Indiana
Product: Cloud platform for aligning bioreactor and lab data, visualization, DOE/statistical analysis, and ML-driven optimization
Key customers: Biopharma, fermentation R&D, and CMOs
Founders: Mitchell Castetter; Joanna Lipinski, PhD
Bioprocess data integration, process development, DOE/statistical analysis, and scale-up optimization for biopharma and fermentation.
2023
Biotechnology
1195000
Investors also include New Stack Ventures
“Techstars (lead investor in pre-seed)”